• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Ann Transl Med . Combined Use of the Neutrophil-To-Lymphocyte Ratio and CRP to Predict 7-day Disease Severity in 84 Hospitalized Patients With COVI

tetano

Editor, Senior Moderator
Ann Transl Med


. 2020 May;8(10):635.
doi: 10.21037/atm-20-2372.
Combined Use of the Neutrophil-To-Lymphocyte Ratio and CRP to Predict 7-day Disease Severity in 84 Hospitalized Patients With COVID-19 Pneumonia: A Retrospective Cohort Study


Yue-Ping Liu[SUP] 1 2 [/SUP], Gao-Ming Li[SUP] 3 [/SUP], Jun He[SUP] 1 [/SUP], Ying Liu[SUP] 4 [/SUP], Min Li[SUP] 1 [/SUP], Rui Zhang[SUP] 3 [/SUP], Ya-Lan Li[SUP] 1 [/SUP], Ya-Zhou Wu[SUP] 3 [/SUP], Bo Diao[SUP] 1 [/SUP]



Affiliations
Free PMC article

Abstract

Background: Coronavirus disease 2019 (COVID-19) has spread rapidly worldwide from Wuhan. An easy-to-use index capable of the early identification of inpatients who are at risk of becoming critically ill is urgently needed in clinical practice. Hence, the aim of this study was to explore an easy-to-use nomogram and a model to triage patients into risk categories to determine the likelihood of developing a critical illness.
Methods: A retrospective cohort study was conducted. We extracted data from 84 patients with laboratory-confirmed COVID-19 from one designated hospital. The primary endpoint was the development of severe/critical illness within 7 days after admission. Predictive factors of this endpoint were selected by LASSO Cox regression model. A nomogram was developed based on selected variables. The predictive performance of the derived nomogram was evaluated by calibration curves and decision curves. Additionally, the predictive performances of individual and combined variables under study were evaluated by receiver operating characteristic curves. The developed model was also tested in a separate validation set with 71 laboratory-confirmed COVID-19 patients.
Results: None of the 84 inpatients were lost to follow-up in this retrospective study. The primary endpoint occurred in 23 inpatients (27.4%). The neutrophil-to-lymphocyte ratio (NLR) and C-reactive protein (CRP) were selected as the final prognostic factors. A nomogram was developed based on the NLR and CRP. The calibration curve and decision curve indicated that the constructed nomogram model was clinically useful. The AUCs for the NLR, CRP and Combined Index in both training set and validation sets were 0.685 (95% CI: 0.574-0.783), 0.764 (95% CI: 0.659-0.850), 0.804 (95% CI: 0.702-0.883), and 0.881 (95% CI: 0.782-0.946), respectively.
Conclusions: Our results demonstrated that the nomogram and Combined Index calculated from the NLR and CRP are potential and reliable predictors of COVID-19 prognosis and can triage patients at the time of admission.

Keywords: C-reactive protein (CRP); Coronavirus disease 2019 (COVID-19); neutrophil-to-lymphocyte ratio (NLR); prognostic; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
 
Back
Top Bottom